Androgen regulation of soluble guanylyl cyclasealpha1 mediates prostate cancer cell proliferation

C Cai1, S-Y Chen, Z Zheng

  • 1Department of Biological Sciences, University of Toledo, Toledo, OH 43606, USA.

Oncogene
|September 12, 2006
PubMed

Insights

Androgen receptor (AR) signaling drives prostate cancer growth. We found soluble guanylyl cyclase alpha1 (sGCalpha1) is an AR target gene that promotes cancer cell proliferation via a novel pathway, independent of nitric oxide (NO).

Area of Science:

  • Molecular Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Prostate cancer progression relies on androgens and the androgen receptor (AR).
  • Soluble guanylyl cyclase (sGC) mediates nitric oxide (NO) effects.
  • AR modulates gene expression to control cellular functions.

Purpose of the Study:

  • Identify novel androgen-regulated genes in prostate cancer.
  • Investigate the role of sGCalpha1 in prostate cancer growth and progression.
  • Elucidate the mechanism of sGCalpha1 action in cancer cells.

Main Methods:

  • Gene microarray analysis to identify androgen-regulated genes.
  • Reporter assays to assess promoter activity and AR-dependency.
  • Gene knockdown and overexpression studies in prostate cancer cell lines.
  • Analysis of sGCalpha1 expression in human prostate cancer tissues.

Main Results:

  • sGCalpha1 identified as a novel androgen-regulated gene.
  • Androgens stimulate sGCalpha1 expression in an AR-dependent manner.
  • sGCalpha1 is crucial for both androgen-dependent and -independent prostate cancer cell growth.
  • sGCalpha1 overexpression enhances prostate cancer cell proliferation.
  • sGCalpha1 exerts growth effects independently of the NO-sGC-cGMP pathway.
  • Elevated sGCalpha1 expression observed in advanced prostate cancer.

Conclusions:

  • sGCalpha1 is a direct AR target gene and promotes prostate cancer growth.
  • sGCalpha1 functions through a novel, NO-independent pathway in prostate cancer.
  • sGCalpha1 represents a potential therapeutic target for advanced prostate cancer.

Related Concept Videos

GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins, also known...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...